As a research center, the Institute conducts clinical trials of investigational new drugs and is a leader in outcome studies. Researchers at The Institute have also devised a unique computerized clinical alert system.
In 2002, the Institute opened the Olin Neuropsychiatry Research Center, a $25 million complex dedicated to research in schizophrenia and other neuropsychiatric disorders. Headed by Godfrey Pearlson, M.D., Olin Center researchers make use of sophisticated neuroimaging techniques and have attracted significant grant funding and competitive awards.
Most of the research at The Institute of Living takes place in the four research centers listed below. Detailed information is provided under each center:
-
The Anxiety Disorders Center specializes in the treatment and study of anxiety-related problems in adults, adolescents, and children. Treatment at the ADC emphasizes cognitive-behavioral therapy, an evidence-based approach to reducing fear and avoidance. Research studies investigate the outcome and process of cognitive-behavioral therapy, as well as the behavioral, cognitive, and neurobiological underpinnings of anxiety.
-
The Clinical Trials Unit supports quality management and program evaluation activities, monitors clinical care (e.g., evidence-based practices), maintains practice guideline documents, and conducts research related to hospital operations.
-
The Olin Neuropsychiatric Research Center conducts neuroscience research in severe psychiatric illnesses and translates that research into new and effective treatments. Conditions studied include schizophrenia, manic-depressive illness, post-traumatic stress disorder, alcohol use disorder, teens with conduct problems, ADHD, PTSD, driving while intoxicated, and Alzheimer’s disease.
-
The HEAT-MIND Lab team conducts epidemiological, basic science, and clinical research into how rising temperatures and extreme heat exposure affect mental health outcomes, especially in young adults with depression and anxiety.